The dilemma of whether to continue TNFα blocker therapy in an ulcerative colitis patient newly diagnosed with a malignant melanoma and melanoma in situ
Affiliation
South Warwickshire University NHS Foundation TrustPublication date
2019-11
Metadata
Show full item recordAbstract
A case report of an ulcerative colitis patient newly diagnosed with a malignant melanoma and melanoma in situ.Citation
Zuzarte L, Mirhadi S, Carr RA, Tso S. The dilemma of whether to continue TNFα blocker therapy in an ulcerative colitis patient newly diagnosed with a malignant melanoma and melanoma in situ. BMJ Case Rep. 2019 Nov 14;12(11):e232536. doi: 10.1136/bcr-2019-232536.Type
ArticleAdditional Links
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6887357/PMID
31732538Journal
BMJ Case ReportsPublisher
BMJ Publishing Groupae974a485f413a2113503eed53cd6c53
10.1136/bcr-2019-232536